“myelodysplastic-syndrome-mds” Archives

in
Entry Author Date Location
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health 01/02/20 National
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street 10/03/19 National
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
Geron’s Drug Alliance with Janssen Terminated, Shares Plummet 68% 09/27/18 San Francisco
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder 07/09/18 Boston
Acceleron’s Blood Drug Hits Phase 3 Goals, Paves Way for FDA Filing 06/28/18 Boston
SeaGen Ends One Leukemia Drug Trial, Stops Enrolling Three Others 06/19/17 Seattle
MEI Pharma Partners with Helsinn on Drug with Potential $464M Payoff 08/08/16 San Diego
Page 1 of 1